167 related articles for article (PubMed ID: 7967706)
21. Formation of 6-thioguanine and 6-mercaptopurine from their 9-alkyl derivatives in mice.
Nelson JA; Vidale E
Cancer Res; 1986 Jan; 46(1):137-40. PubMed ID: 3940185
[TBL] [Abstract][Full Text] [Related]
22. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
Landier W; Hageman L; Chen Y; Kornegay N; Evans WE; Bostrom BC; Casillas J; Dickens DS; Angiolillo AL; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Relling MV; Wong FL; Bhatia S
J Clin Oncol; 2017 May; 35(15):1730-1736. PubMed ID: 28339328
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
[TBL] [Abstract][Full Text] [Related]
24. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
Nandy P; Periclou AP; Avramis VI
Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
[TBL] [Abstract][Full Text] [Related]
25. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
[TBL] [Abstract][Full Text] [Related]
26. Metabolic effects of thiopurine derivatives against human CCRF-CEM leukaemia cells.
Shi RZ; Lyons SD; Christopherson RI
Int J Biochem Cell Biol; 1998 Aug; 30(8):885-95. PubMed ID: 9744080
[TBL] [Abstract][Full Text] [Related]
27. The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.
Karim H; Hashemi J; Larsson C; Moshfegh A; Fotoohi AK; Albertioni F
Biochem Biophys Res Commun; 2011 Jul; 411(1):156-61. PubMed ID: 21723252
[TBL] [Abstract][Full Text] [Related]
28. Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate.
Giverhaug T; Loennechen T; Aarbakke J
Biochem Pharmacol; 1998 May; 55(10):1641-6. PubMed ID: 9634000
[TBL] [Abstract][Full Text] [Related]
29. Impact of
Ruel NM; Nguyen KH; Kim CS; Andrade LPS; Hammond JR
J Pharmacol Exp Ther; 2022 Sep; 382(3):335-345. PubMed ID: 35798387
[TBL] [Abstract][Full Text] [Related]
30. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
Zimm S; Johnson GE; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
[TBL] [Abstract][Full Text] [Related]
31. An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells.
Oliveira BM; Romanha AJ; Alves TM; Viana MB; Zani CL
Braz J Med Biol Res; 2004 May; 37(5):649-58. PubMed ID: 15107925
[TBL] [Abstract][Full Text] [Related]
32. Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia.
Larsen RH; Utke Rank C; Grell K; Nørgaard Møller L; Malthe Overgaard U; Kampmann P; Nersting J; Degn M; Nygaard Nielsen S; Holst H; Klug Albertsen B; Skov Wehner P; Thude Callesen M; Kanerva J; Leth Frandsen T; Als-Nielsen B; Lyngsie Hjalgrim L; Schmiegelow K
Haematologica; 2021 Nov; 106(11):2824-2833. PubMed ID: 34047177
[TBL] [Abstract][Full Text] [Related]
33. Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment.
Zaza G; Cheok M; Yang W; Panetta JC; Pui CH; Relling MV; Evans WE
Blood; 2005 Sep; 106(5):1778-85. PubMed ID: 15905191
[TBL] [Abstract][Full Text] [Related]
34. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells.
Panetta JC; Evans WE; Cheok MH
Br J Cancer; 2006 Jan; 94(1):93-100. PubMed ID: 16333308
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy.
Warren DJ; Andersen A; Slørdal L
Cancer Res; 1995 Apr; 55(8):1670-4. PubMed ID: 7712473
[TBL] [Abstract][Full Text] [Related]
37. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
[TBL] [Abstract][Full Text] [Related]
38. Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.
Oancea I; Movva R; Das I; Aguirre de Cárcer D; Schreiber V; Yang Y; Purdon A; Harrington B; Proctor M; Wang R; Sheng Y; Lobb M; Lourie R; Ó Cuív P; Duley JA; Begun J; Florin TH
Gut; 2017 Jan; 66(1):59-69. PubMed ID: 27411368
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia.
Escherich G; Richards S; Stork LC; Vora AJ;
Leukemia; 2011 Jun; 25(6):953-9. PubMed ID: 21372841
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of LC-MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism.
Al-Ghobashy MA; Hassan SA; Abdelaziz DH; Elhosseiny NM; Sabry NA; Attia AS; El-Sayed MH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():88-94. PubMed ID: 27802917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
